Literature DB >> 33610557

Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.

George R Nahass1, Yuanzi Sun2, Yong Xu3, Mark Batchelor2, Madeleine Reilly2, Iryna Benilova2, Niraja Kedia4, Kevin Spehar4, Frank Sobott3, Richard B Sessions5, Byron Caughey6, Sheena E Radford3, Parmjit S Jat2, John Collinge2, Jan Bieschke7.   

Abstract

Alpha-synuclein (α-syn) fibrils, a major constituent of the neurotoxic Lewy Bodies in Parkinson's disease, form via nucleation dependent polymerization and can replicate by a seeding mechanism. Brazilin, a small molecule derived from red cedarwood trees in Brazil, has been shown to inhibit the fibrillogenesis of amyloid-beta (Aβ) and α-syn as well as remodel mature fibrils and reduce cytotoxicity. Here we test the effects of Brazilin on both seeded and unseeded α-syn fibril formation and show that the natural polyphenol inhibits fibrillogenesis of α-syn by a unique mechanism that alters conformational equilibria in two separate points of the assembly mechanism: Brazilin preserves the natively unfolded state of α-syn by specifically binding to the compact conformation of the α-syn monomer. Brazilin also eliminates seeding competence of α-syn assemblies from Parkinson's disease patient brain tissue, and reduces toxicity of pre-formed assemblies in primary neurons by inducing the formation of large fibril clusters. Molecular docking of Brazilin shows the molecule to interact both with unfolded α-syn monomers and with the cross-β sheet structure of α-syn fibrils. Our findings suggest that Brazilin has substantial potential as a neuroprotective and therapeutic agent for Parkinson's disease.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Amyloid; Molecular Modelling; Neurdegeneration; Parkinson’s disease; Polyphenol

Mesh:

Substances:

Year:  2021        PMID: 33610557      PMCID: PMC7610480          DOI: 10.1016/j.jmb.2021.166878

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  67 in total

1.  Ab initio protein structure prediction using physicochemical potentials and a simplified off-lattice model.

Authors:  N Gibbs; A R Clarke; R B Sessions
Journal:  Proteins       Date:  2001-05-01

2.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

Review 3.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

Review 4.  Secondary nucleation in amyloid formation.

Authors:  Mattias Törnquist; Thomas C T Michaels; Kalyani Sanagavarapu; Xiaoting Yang; Georg Meisl; Samuel I A Cohen; Tuomas P J Knowles; Sara Linse
Journal:  Chem Commun (Camb)       Date:  2018-08-02       Impact factor: 6.222

5.  EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.

Authors:  Jan Bieschke; Jenny Russ; Ralf P Friedrich; Dagmar E Ehrnhoefer; Heike Wobst; Katja Neugebauer; Erich E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

6.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

7.  Amyloid-β(1-42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity.

Authors:  Sha Jin; Niraja Kedia; Eva Illes-Toth; Ivan Haralampiev; Simon Prisner; Andreas Herrmann; Erich E Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-07-25       Impact factor: 5.157

Review 8.  Interactions between metals and alpha-synuclein--function or artefact?

Authors:  David R Brown
Journal:  FEBS J       Date:  2007-07-06       Impact factor: 5.542

9.  Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.

Authors:  Eri Saijo; Bradley R Groveman; Allison Kraus; Michael Metrick; Christina D Orrù; Andrew G Hughson; Byron Caughey
Journal:  Methods Mol Biol       Date:  2019

10.  Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.

Authors:  Anne Stuendl; Marcel Kunadt; Niels Kruse; Claudia Bartels; Wiebke Moebius; Karin M Danzer; Brit Mollenhauer; Anja Schneider
Journal:  Brain       Date:  2015-12-08       Impact factor: 13.501

View more
  1 in total

1.  VCP suppresses proteopathic seeding in neurons.

Authors:  Jiang Zhu; Sara Pittman; Dhruva Dhavale; Rachel French; Jessica N Patterson; Mohamed Salman Kaleelurrrahuman; Yuanzi Sun; Jaime Vaquer-Alicea; Gianna Maggiore; Christoph S Clemen; William J Buscher; Jan Bieschke; Paul Kotzbauer; Yuna Ayala; Marc I Diamond; Albert A Davis; Conrad Weihl
Journal:  Mol Neurodegener       Date:  2022-04-12       Impact factor: 18.879

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.